Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Research Article

Comparing the Sensitivity and Specificity of Lung CT-scan with RT-PCR for Diagnosis of COVID-19

Author(s): Akram Asghari, Seyed-Hasan Adeli, Mahmoud Parham, Mohammad Bagherzade, Sajjad Ahmadpour*, Rasoul Shajari, Reihane Tabarrai, Masoumeh Shakeri, Mohammad Amin Habibi, Amir Jabbari, Saeede Jafari, Fatemesadat Razavinia, Seyed Yaser Foroghi Ghomi, Ali Ebrazeh and Jamshid Vafaeimanesh*

Volume 19, Issue 4, 2023

Published on: 26 August, 2022

Article ID: e200622206204 Pages: 6

DOI: 10.2174/1573405618666220620141012

Price: $65

Abstract

Background: The lung is one of the major organs affected by the SARS-CoV-2 virus. Lung CT scan and RT-PCR are the most valuable diagnostic methods in the early diagnosis and management of COVID-19. Due to the possible inconsistency of the false-negative results for the RT-PCR test, in our study, we aimed to evaluate the sensitivity and specificity of lung CT-scan as an accurate diagnostic method of COVID-19.

Methods: In this cross-sectional study, patients suspected of COVID-19 and referred to Shahid Beheshti Hospital in Qom city from February 26 to April 13, 2020, were enrolled. For a definitive diagnosis of COVID-19, chest CT scan and RT-PCR testing was performed for 644 patients, and both sensitivity and specificity of lung CT scan were evaluated.

Results: According to the findings, and comparing to the RT-PCR test as the gold standard, sensitivity, specificity as well as, positive predictive and negative predictive values of lung CT-scan were found as follow; 94.47% (95% CI: 90.73 - 97.02%), 24.71% (95% CI: 20.70 - 29.07%), 40.73% (95% CI: 36.58 - 44.99%), 89.08% (95% CI: 82.4 - 94.05%), respectively.

Conclusion: According to the findings, the lung CT scan has a better diagnostic value than RTPCR in symptomatic patients who were referred to the hospital for COVID-19 diagnosis. Performing lung CT-scan in patients with negative RT-PCR tests should be assessed.

Keywords: COVID-19, CT scan, RT-PCR, diagnosis, sensitivity, specificity.

Graphical Abstract

[1]
McIntosh K. Current topics in microbiology and immunology/Ergebnisse der Mikrobiologie und Immunitätsforschung. Coronaviruses: A comparative review 1974; 85-129.
[http://dx.doi.org/10.1007/978-3-642-65775-7_3]
[2]
Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382(8): 727-33.
[http://dx.doi.org/10.1056/NEJMoa2001017] [PMID: 31978945]
[3]
Phelan AL, Katz R, Gostin LO. The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. JAMA 2020; 323(8): 709-10.
[http://dx.doi.org/10.1001/jama.2020.1097] [PMID: 31999307]
[4]
Adhikari SP, Meng S, Wu Y-J, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of Coronavirus Disease (COVID-19) during the early outbreak period: A scoping review. Infect Dis Poverty 2020; 9(1): 29.
[http://dx.doi.org/10.1186/s40249-020-00646-x] [PMID: 32183901]
[5]
Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA 2020; 323(14): 1406-7.
[http://dx.doi.org/10.1001/jama.2020.2565] [PMID: 32083643]
[6]
Hormati A, Ghadir MR, Zamani F, Khodadadi J, Afifian M, Ahmadpour S. Preventive strategies used by GI physicians during the COVID-19 pandemic. New Microbes New Infect 2020; 35: 100676.
[http://dx.doi.org/10.1016/j.nmni.2020.100676] [PMID: 32292589]
[7]
Hormati A, Ghadir MR, Zamani F, et al. Are there any association between COVID-19 severity and immunosuppressive therapy? Immunol Lett 2020; 224: 12-3.
[http://dx.doi.org/10.1016/j.imlet.2020.05.002] [PMID: 32473971]
[8]
Nair R, Perencevich EN, Goto M, et al. Patient care experience with utilization of isolation precautions: Systematic literature review and meta-analysis. Clin Microbiol Infect 2020; 26(6): 684-95.
[http://dx.doi.org/10.1016/j.cmi.2020.01.022] [PMID: 32006691]
[9]
Chhikara BS, Rathi B, Singh J, Poonam F. Corona virus SARS-CoV-2 disease COVID-19: Infection, prevention and clinical advances of the prospective chemical drug therapeutics. Chemical Biology Letters 2020; 7(1): 63-72.
[10]
Chhikara BS, Kumar R, Bazard P, Varma RS. Viral infection mitigations using advanced nanomaterials and tools: Lessons from SARS-CoV-2 for future prospective interventions. J Mat NanoSci 2021; 8(2): 64-82.
[11]
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497-506.
[http://dx.doi.org/10.1016/S0140-6736(20)30183-5] [PMID: 31986264]
[12]
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382(18): 1708-20.
[http://dx.doi.org/10.1056/NEJMoa2002032] [PMID: 32109013]
[13]
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020; 395(10223): 507-13.
[http://dx.doi.org/10.1016/S0140-6736(20)30211-7] [PMID: 32007143]
[14]
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020; 17(5): 259-60.
[http://dx.doi.org/10.1038/s41569-020-0360-5] [PMID: 32139904]
[15]
Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016; 24(6): 490-502.
[http://dx.doi.org/10.1016/j.tim.2016.03.003] [PMID: 27012512]
[16]
Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet 2020; 395(10223): 514-23.
[http://dx.doi.org/10.1016/S0140-6736(20)30154-9] [PMID: 31986261]
[17]
Shen C, Wang Z, Zhao F, et al. Treatment of 5 critically Ill patients with COVID-19 with convalescent plasma. JAMA 2020; 323(16): 1582-9.
[http://dx.doi.org/10.1001/jama.2020.4783] [PMID: 32219428]
[18]
Tran DH, Cuong HQ, Tran HT, et al. A comparative study of isothermal nucleic acid amplification methods for SARS-CoV-2 detection at point-of-care. BioRxiv 2021; 2020: 2020-05.
[19]
Yan Y, Chang L, Wang L. Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures. Rev Med Virol 2020; 30(3): e2106.
[http://dx.doi.org/10.1002/rmv.2106] [PMID: 32302058]
[20]
Fang Y, Zhang H, Xu Y, Xie J, Pang P, Ji W. CT manifestations of two cases of 2019 Novel Coronavirus (2019-nCoV) pneumonia. Radiology 2020; 295(1): 208-9.
[http://dx.doi.org/10.1148/radiol.2020200280] [PMID: 32031481]
[21]
Ng MY, Lee EYP, Yang J, et al. Imaging profile of the COVID-19 infection: Radiologic findings and literature review. Radiol Cardiothorac Imaging 2020; 2(1): e200034.
[http://dx.doi.org/10.1148/ryct.2020200034] [PMID: 33778547]
[22]
Pan F, Ye T, Sun P, et al. Time course of lung changes at chest CT during recovery from Coronavirus Disease 2019 (COVID-19). Radiology 2020; 295(3): 715-21.
[http://dx.doi.org/10.1148/radiol.2020200370] [PMID: 32053470]
[23]
Machnicki S, Patel D, Singh A, et al. The usefulness of chest CT imaging in patients with suspected or diagnosed COVID-19: A review of literature. Chest 2021; 160(2): 652-70.
[http://dx.doi.org/10.1016/j.chest.2021.04.004] [PMID: 33861993]
[24]
Varadarajan V, Shabani M, Ambale Venkatesh B, Lima JAC. Role of imaging in diagnosis and management of COVID-19: A multiorgan multimodality imaging review. Front Med (Lausanne) 2021; 8: 765975.
[http://dx.doi.org/10.3389/fmed.2021.765975] [PMID: 34820400]
[25]
Chung M, Bernheim A, Mei X, et al. CT imaging features of 2019 Novel Coronavirus (2019-nCoV). Radiology 2020; 295(1): 202-7.
[http://dx.doi.org/10.1148/radiol.2020200230] [PMID: 32017661]
[26]
Kanne JP, Little BP, Chung JH, Elicker BM, Ketai LH. Essentials for radiologists on COVID-19: An update-radiology scientific expert panel. Radiology 2020; 296(2): E113-4.
[http://dx.doi.org/10.1148/radiol.2020200527] [PMID: 32105562]
[27]
Sabri YY, Fawzi MMT, Nossair EZ, El-Mandooh SM, Hegazy AA, Tadros SF. CT findings of 795 COVID-19 positive cases: A multicenter study in Egypt. Egypt J Radiol Nucl Med 2020; 51(1): 1-9.
[28]
Kwee TC, Kwee RM. Chest CT in COVID-19: What the radiologist needs to know. Radiographics 2020; 40(7): 1848-65.
[http://dx.doi.org/10.1148/rg.2020200159] [PMID: 33095680]
[29]
Vicini S, Panvini N, Bellini D, et al. Radiographers and COVID-19 pneumonia: Diagnostic performance using CO-RADS. Radiography 2021; 27(4): 1078-84.
[http://dx.doi.org/10.1016/j.radi.2021.04.010] [PMID: 33975783]
[30]
Jin C, Tian C, Wang Y, et al. A pattern categorization of CT findings to predict outcome of COVID-19 pneumonia. Front Public Health 2020; 8: 567672.
[http://dx.doi.org/10.3389/fpubh.2020.567672] [PMID: 33072703]
[31]
Lei J, Li J, Li X, Qi X. CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) pneumonia. Radiology 2020; 295(1): 18.
[http://dx.doi.org/10.1148/radiol.2020200236] [PMID: 32003646]
[32]
Fang Y, Zhang H, Xie J, et al. Sensitivity of chest CT for COVID-19: Comparison to RT-PCR. Radiology 2020; 296(2): E115-7.
[http://dx.doi.org/10.1148/radiol.2020200432] [PMID: 32073353]
[33]
Ai T, Yang Z, Hou H, et al. Correlation of chest CT and RT-PCR testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 cases. Radiology 2020; 296(2): E32-40.
[http://dx.doi.org/10.1148/radiol.2020200642] [PMID: 32101510]
[34]
Yang Y, Yang M, Shen C, et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections. MedRxiv 2020; 2020; 1-17.
[http://dx.doi.org/10.1101/2020.02.11.20021493]
[35]
Alhazzani W, Møller MH, Arabi YM, et al. Surviving sepsis campaign: Guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020; 46(5): 854-87.
[http://dx.doi.org/10.1007/s00134-020-06022-5] [PMID: 32222812]
[36]
Bernheim A, Mei X, Huang M, et al. Chest CT findings in Coronavirus Disease-19 (COVID-19): Relationship to duration of infection. Radiology 2020; 295(3): 200463.
[http://dx.doi.org/10.1148/radiol.2020200463] [PMID: 32077789]
[37]
Dinnes J, Deeks JJ, Berhane S, et al. Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection. Cochrane Database Sys Rev 2020; 8(8): CD013705.
[38]
Watson J, Whiting PF, Brush JE. Interpreting a covid-19 test result. BMJ 2020; 369: m1808.
[http://dx.doi.org/10.1136/bmj.m1808] [PMID: 32398230]
[39]
Jalaber C, Lapotre T, Morcet-Delattre T, Ribet F, Jouneau S, Lederlin M. Chest CT in COVID-19 pneumonia: A review of current knowledge. Diagn Interv Imaging 2020; 101(7-8): 431-7.
[http://dx.doi.org/10.1016/j.diii.2020.06.001] [PMID: 32571748]
[40]
Thomas C, Naudin M, Tasu J-P, et al. Efficacy of chest CT scan for COVID-19 diagnosis in a low prevalence and incidence region. Eur Radiol 2021; 31(11): 8141-6.
[http://dx.doi.org/10.1007/s00330-021-07863-4] [PMID: 33871709]
[41]
Zhou J, Liao X, Cao J, Ling G, Ding X, Long Q. Differential diagnosis between the coronavirus disease 2019 and Streptococcus pneumoniae pneumonia by thin-slice CT features. Clin Imaging 2021; 69: 318-23.
[http://dx.doi.org/10.1016/j.clinimag.2020.09.012] [PMID: 33045476]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy